Evidence map›Paper›PMID 28365780›Full record

ArticleHuman molecular genetics2017

Mosaic synaptopathy and functional defects in Cav1.4 heterozygous mice and human carriers of CSNB2.

Stylianos Michalakis, Lior Shaltiel, Vithiyanjali Sothilingam, Susanne Koch, Verena Schludi, Stefanie Krause, Christina Zeitz, Isabelle Audo, Marie-Elise Lancelot, Christian Hamel and 11 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Human molecular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Stylianos MichalakisCenter for Integrated Protein Science Munich (CIPSM) and Department of PharmacyCenter for Drug Research, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Lior ShaltielCenter for Integrated Protein Science Munich (CIPSM) and Department of PharmacyCenter for Drug Research, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Vithiyanjali SothilingamDivision of Ocular Neurodegeneration, Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, 72076 Tübingen, Germany.
Susanne KochCenter for Integrated Protein Science Munich (CIPSM) and Department of PharmacyCenter for Drug Research, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Verena SchludiCenter for Integrated Protein Science Munich (CIPSM) and Department of PharmacyCenter for Drug Research, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Stefanie KrauseCenter for Integrated Protein Science Munich (CIPSM) and Department of PharmacyCenter for Drug Research, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Christina ZeitzINSERM, UMR_S968, Paris F-75012, France.
Isabelle AudoINSERM, UMR_S968, Paris F-75012, France.
Marie-Elise LancelotINSERM, UMR_S968, Paris F-75012, France.
Christian HamelCHRU, Genetics of Sensory Diseases, Montpellier 34091, France.
Isabelle MeunierCHRU, Genetics of Sensory Diseases, Montpellier 34091, France.
Markus N PreisingDepartment of Ophthalmology, Justus-Liebig-University Giessen, Universitätsklinikum Giessen and Marburg GmbH, Giessen Campus, 35392 Giessen, Germany.
Christoph FriedburgDepartment of Ophthalmology, Justus-Liebig-University Giessen, Universitätsklinikum Giessen and Marburg GmbH, Giessen Campus, 35392 Giessen, Germany.
Birgit LorenzDepartment of Ophthalmology, Justus-Liebig-University Giessen, Universitätsklinikum Giessen and Marburg GmbH, Giessen Campus, 35392 Giessen, Germany.
Nawal ZabouriNeuroanatomy, Max-Planck-Institute for Brain Research, 60438 Frankfurt/M, Germany.
Silke HaverkampNeuroanatomy, Max-Planck-Institute for Brain Research, 60438 Frankfurt/M, Germany.
Marina Garcia GarridoDivision of Ocular Neurodegeneration, Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, 72076 Tübingen, Germany.
Naoyuki TanimotoDivision of Ocular Neurodegeneration, Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, 72076 Tübingen, Germany.
Mathias W SeeligerDivision of Ocular Neurodegeneration, Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, 72076 Tübingen, Germany.
Martin BielCenter for Integrated Protein Science Munich (CIPSM) and Department of PharmacyCenter for Drug Research, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Christian A Wahl-SchottCenter for Integrated Protein Science Munich (CIPSM) and Department of PharmacyCenter for Drug Research, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28365780
PMCPMC7190878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.